Delivery Order SPE2DB20D1100-SPE2DB24FC9A8
Award Date
7/24/24
Potential Completion Date
7/25/24
Potential Value
$2.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of 4,565,778,830 units of the pharmaceutical product CATHFLO ACTIVASE 2 MG VIALS. The contract has a ceiling value of $9,654.84 and a period of performance through September 13, 2024. The contract is a firm-fixed-price delivery order, with no set-aside designation. Amerisourcebergen, a major pharmaceutical distributor, has been awarded this contract to provide critical...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $1,070.90 order is for 2 milligram vials of Cathflo Activase, a pharmaceutical product. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through December 2025. This IDC serves as the primary vehicle for Amerisourcebergen to...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $3,197.14 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical to supply CATHFLO ACTIVASE 2 MG VIALS. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded by DLA to Amerisourcebergen Drug Corp as the sole prime contractor. The IDC, which does not fall under any overarching contract...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,566,061,611 units of the medication "CATHFLO ACTIVASE 2 MG VIALS" with a ceiling value of $1,392.17. The contract is a firm fixed-price delivery order with an ultimate completion date of October 10, 2024. Amerisourcebergen is a for-profit organization that has been awarded multiple federal...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of CATHFLO ACTIVASE 2 MG VIALS, a medical product, and has a ceiling value of $7,430.36. The contract is a Firm Fixed Price, Delivery Order type, and does not have a set-aside designation, indicating open competition. In addition to this delivery order, AmerisourceBergen holds a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,213.34 firm fixed-price contract is for the supply of 4562520291 CATHFLO ACTIVASE 2 MG VIALS medical product. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as...
This federal contract award is for the delivery of Cathflo Activase 2 mg vials to the Defense Logistics Agency (DLA). The $5,031.53 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, on October 7, 2024 with a completion date of October 8, 2024. The contract does not have a set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued...
This is a federal contract award made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of 4,562,676,853 units of the pharmaceutical product CATHFLO ACTIVASE 2 MG VIALS. The contract has a ceiling value of $5,025.12 and an ultimate completion date of November 2, 2023. This is a delivery order contract with a firm fixed price pricing type. The contract was not set aside...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a for-profit pharmaceutical sourcing and distribution company. The $5,140.32 firm fixed price contract is for the delivery of CATHFLO ACTIVASE 2 MG VIALS to Conshohocken, Pennsylvania. This delivery order is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp to provide a...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, issued by the Defense Logistics Agency (DLA), is for the supply of CATHFLO ACTIVASE 2 MG VIALS, a critical pharmaceutical product. The $2,570.16 firm fixed-price delivery order has a completion date of July 11, 2024. Amerisourcebergen, a major pharmaceutical distributor, is leveraging its extensive supply chain network to fulfill this contract. The company holds a larger Indefinite Delivery Contract (IDC)...